| Date Filed | Type | Description |
| 03/29/2023 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 02/10/2023 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 02/10/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 05/04/2022 |
SC 13D/A
| Arix Bioscience plc reports a 5.6% stake in LogicBio Therapeutics, Inc. |
| 02/15/2022 |
SC 13D/A
| Arix Bioscience plc reports a 6.6% stake in LogicBio Therapeutics, Inc. |
| 02/10/2022 |
SC 13G/A
| Arix Bioscience plc has filed a Schedule 13D for Aura Biosciences, Inc. |
| 11/10/2021 |
SC 13G
| Arix Bioscience plc reports a 5.3% stake in Aura Biosciences, Inc. |
| 10/26/2021 |
SC 13D/A
| Arix Bioscience plc reports a 9.2% stake in LogicBio Therapeutics, Inc. |
| 07/20/2021 |
SC 13D/A
| Arix Bioscience plc reports a 9% stake in Imara Inc. |
| 07/15/2021 |
SC 13D/A
| Arix Bioscience plc reports a 6.7% stake in Harpoon Therapeutics, Inc. |
| 02/17/2021 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 01/12/2021 |
SC 13D/A
| Arix Bioscience plc reports a 6.9% stake in Harpoon Therapeutics, Inc. |
| 01/08/2021 |
SC 13D/A
| Arix Bioscience plc reports a 6.1% stake in Imara Inc. |
| 01/08/2021 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 12/04/2020 |
SC 13D/A
| Arix Bioscience plc reports a 8.4% stake in Imara Inc. |
| 10/05/2020 |
4
| Arix Bioscience plc (10% Owner) has filed a Form 4 on LogicBio Therapeutics, Inc.|
Txns:
| Sold 16,332 shares
@ $8.559, valued at
$139.8k
Sold 31,101 shares
@ $9.24, valued at
$287.4k
Sold 36,983 shares
@ $9.249, valued at
$342.1k
Sold 22,651 shares
@ $9.004, valued at
$203.9k
Sold 2,709 shares
@ $8.781, valued at
$23.8k
Sold 1,335 shares
@ $8.79, valued at
$11.7k
Sold 159 shares
@ $8.75, valued at
$1.4k
Sold 38,514 shares
@ $7.629, valued at
$293.8k
Sold 174,219 shares
@ $7.077, valued at
$1.2M
Sold 273,584 shares
@ $7.5365, valued at
$2.1M
|
|
| 09/29/2020 |
SC 13D/A
| Arix Bioscience plc reports a 10.1% stake in LogicBio Therapeutics, Inc. |
| 06/05/2020 |
SC 13D/A
| Arix Bioscience plc reports a 2.2% stake in Iterum Therapeutics plc |
| 06/01/2020 |
SC 13D/A
| Arix Bioscience plc reports a 8.8% stake in Harpoon Therapeutics, Inc. |
| 05/29/2020 |
4
| Arix Bioscience plc (10% Owner) has filed a Form 4 on Harpoon Therapeutics, Inc.|
Txns:
| Sold 12,064 shares
@ $22.3926, valued at
$270.1k
Sold 366,591 shares
@ $21.3342, valued at
$7.8M
|
|
| 03/24/2020 |
SC 13D
| Arix Bioscience plc reports a 9.4% stake in Imara Inc. |
| 03/16/2020 |
4
| Arix Bioscience plc (10% Owner) has filed a Form 4 on IMARA Inc.|
Txns:
| Converted 1,367,058 shares
@ $0
Bought 187,500 shares
@ $16, valued at
$3M
Converted 8,611,110 preferred shares
@ $0 |
|
| 03/11/2020 |
3
| Arix Bioscience plc (10% Owner) has filed a Form 3 on IMARA Inc. |
| 01/27/2020 |
SC 13D/A
| Arix Bioscience plc reports a 7.4% stake in Iterum Therapeutics plc |
| 12/17/2019 |
4
| Arix Bioscience plc (10% Owner) has filed a Form 4 on Harpoon Therapeutics, Inc.|
Txns:
| Sold 11,002 shares
@ $17.2097, valued at
$189.3k
Sold 13,080 shares
@ $17.0245, valued at
$222.7k
Sold 12,476 shares
@ $16.8298, valued at
$210k
|
|
| 12/11/2019 |
SC 13D/A
| Arix Bioscience plc reports a 10.6% stake in Harpoon Therapeutics, Inc. |
| 12/10/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/22/2019 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
| 02/14/2019 |
4
| Arix Bioscience plc (10% Owner) has filed a Form 4 on Harpoon Therapeutics, Inc.|
Txns:
| Converted 2,463,548 shares
@ $0
Bought 428,571 shares
@ $14, valued at
$6M
Converted 1,720,698 convertible preferred
@ $0
Converted 742,850 convertible preferred
@ $0 |
|
| 02/07/2019 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 11/02/2018 |
SC 13D
| Arix Bioscience plc reports a 13% stake in LogicBio Therapeutics, Inc. |
| 10/26/2018 |
4
| Arix Bioscience plc (10% Owner) has filed a Form 4 on LogicBio Therapeutics, Inc.|
Txns:
| Converted 2,279,023 shares
@ $0
Bought 700,000 shares
@ $10, valued at
$7M
Converted 4,352,775 preferred shares
@ $0 |
|
| 10/25/2018 |
3/A
| Arix Bioscience plc (10% Owner) has filed a Form 3/A on LogicBio Therapeutics, Inc. |
| 10/19/2018 |
3
| Arix Bioscience plc (10% Owner) has filed a Form 3 on LogicBio Therapeutics, Inc. |
|